Search by Drug Name or NDC
NDC 50090-0285-01 temazepam 30 mg/1 Details
temazepam 30 mg/1
temazepam is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is TEMAZEPAM.
MedlinePlus Drug Summary
Temazepam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 50090-0285-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Temazepam
Product Information
| NDC | 50090-0285 |
|---|---|
| Product ID | 50090-0285_bbd2d9f6-7d69-46d6-920d-265715b8d218 |
| Associated GPIs | 60201030000110 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | temazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | temazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | TEMAZEPAM |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA071457 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-0285-01 (50090028501)
| NDC Package Code | 50090-0285-1 |
|---|---|
| Billing NDC | 50090028501 |
| Package | 30 CAPSULE in 1 BOTTLE (50090-0285-1) |
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |